The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...
However, a decision taken by the company earlier in 2024 underlined how researchers in sectors like drug discovery see the importance of the tool by triggering the creation of multiple workalikes ...
In other developments, the EPA updated emission standards for polyether polyols and declined to regulate 9 drinking-water contaminants ...
Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...
Paris Wilson, 35, denied planning to murder her ex-husband Danny Cahalane, who was 'doused in acid' in his own home after the ...
Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.
This week on "The Readout LOUD," a conversation with biotech "godfather" Stelios Papadapolous live from #STATBreakthrough.
The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to $8.49 billion.
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.